Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10299192 | European Neuropsychopharmacology | 2014 | 13 Pages |
Abstract
Schizophrenia continues to pose a serious challenge to neuroscience and psychiatry as well as to health care systems and to the patients and families who suffer this terrible and disabling illness. Major developments in the past few months in both genetics and drug development oblige us to consider novel drug discovery tactics for future schizophrenia research. Here we review what we consider to be the key issues and some suggested solutions.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
David J. Nutt, Anna C. Need,